A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Neoplasm Recurrence, Local
  • Paclitaxel
  • Taxoids

abstract

  • The combination of docetaxel and estramustine produced responses in heavily pretreated women with MBC while maintaining quality of life.

publication date

  • February 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.11082

PubMed ID

  • 12548594

Additional Document Info

start page

  • 537

end page

  • 44

volume

  • 97

number

  • 3